This infographic explores how patients and practitioners alike can overcome the challenges of urine collection.
When properly collected, first-void urine, the first 10 mL- 40 mL of urine, can help detect breast, ovarian, and pancreatic cancer and screen for sexually transmitted infections such as human papillomavirus and chlamydia. But this low-cost, non-invasive procedure presents challenges that can impact patient experience, accuracy of results, and research. Now there is a novel first-void urine collection device that is producing better outcomes, and that 97% of users would use again.
Get the infographic that explores why sample collection is so challenging and the novel device that is a reliable solution. You’ll learn:
Offered Free by: BioPharma Dive's studioID and DNA Genotek
See All Resources from: BioPharma Dive's studioID and DNA Genotek
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.